CD4+ and CD8+ T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions

Area of Science:

• Immunology
• Cellular Immunology
• T cell biology

Background:

• Contact hypersensitivity (CHS) is mediated by IFN-gamma-producing CD8(+) T cells, with CD4(+) T cells regulating response intensity.
• The role of CD40-CD154 engagement in priming CD8(+) and CD4(+) T cells by hapten-presenting Langerhans cells (hpLC) was unclear.

Purpose of the Study:

• To investigate the necessity of CD40-CD154 interactions for CD8(+) and CD4(+) T cell priming in contact hypersensitivity (CHS).
• To elucidate the mechanism by which anti-CD154 monoclonal antibody (mAb) affects T cell development and CHS responses.

Main Methods:

• Comparison of CHS responses in wild-type and CD154(-/-) mice.
• Administration of anti-CD154 mAb (MR1) or its F(ab')(2) fragment during hapten sensitization.
• Assessment of T cell populations (CD8(+) and CD4(+)) and their cytokine production (IFN-gamma, IL-4).
• In vitro proliferation assays using hpLC and hapten-primed T cells from treated mice.
• Experiments involving CD4(+) T cell depletion or CD4(-/-) mice.

Main Results:

• CHS responses to dinitrofluorobenzene (DNFB) were similar in wild-type and CD154(-/-) mice.
• Anti-CD154 mAb MR1 inhibited hapten-specific CD8(+) T cell development and CHS responses, but not CD4(+) T cell development.
• The inhibitory effect of anti-CD154 mAb was indirect, mediated through CD4(+) T cells, impairing hpLC stimulatory capacity.

Conclusions:

• CD40-CD154 interactions are not essential for the development of IFN-gamma-producing CD8(+) T cells or CHS responses.
• Anti-CD154 mAb inhibits CD8(+) T cell development and CHS responses through an indirect mechanism involving CD4(+) T cells.
• This study proposes a novel pathway where anti-CD154 mAb impacts hpLC function via CD4(+) T cells, affecting CD8(+) T cell priming.